Application of bronchoalveolar lavage fluid in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation.
10.3760/cma.j.issn.0253-2727.2019.10.005
- VernacularTitle:支气管肺泡灌洗液病原体检测在异基因造血干细胞移植后肺部并发症中的诊断价值
- Author:
Shu LI
1
;
Li Ping WAN
;
Guo Gang XIE
;
Ai Hua BAO
;
Yi SUN
;
Wen SHU
;
Jie Ling JIANG
;
Jun YANG
;
Xian Min SONG
;
Chun WANG
Author Information
1. Department of Hematology, Shanghai Jiao Tong University Affiliated Shanghai General Hospital, Shanghai 200080, China.
- Publication Type:Journal Article
- Keywords:
Allogeneic hematopoietic stem cell transplantation;
Bronchoalveolar lavage fluid;
Pneumonia, cytomegalovirus;
Pulmonary complication
- MeSH:
Bronchoalveolar Lavage;
Bronchoalveolar Lavage Fluid;
Hematopoietic Stem Cell Transplantation/adverse effects*;
Humans;
Pneumonia/etiology*;
Prospective Studies
- From:
Chinese Journal of Hematology
2019;40(10):822-826
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To evaluate the diagnostic value of bronchoalveolar lavage (BAL) for pulmonary complications in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and its safety. Methods: Patients with pulmonary complications after allo-HSCT underwent BAL. Microbiological smears, culture, PCR of CMV-DNA, EBV-DNA and TB-DNA, macro genomes new generation sequencing (mNGS) techniques were performed to detect pathogens in BAL fluid (BALF) . Results: A total of 73 allo-HSCT patients with 86 times of pulmonary complications enrolled this prospective study. They underwent 132 times of BAL procedures. The clinical diagnoses of 88.4% cases were made based on BALF analysis. Of them, 67 cases (77.9%) had infectious pulmonary complications, including 29 cases (33.7%) of fungal infection, 18 cases (20.9%) of mixed infection, 11 cases (12.8%) of viral infection and 9 cases (10.5%) of bacterial infection. The other 9 cases (10.5%) of non-infectious pulmonary complications included 8 cases (9.3%) of idiopathic pneumonia syndrome (IPS) and 1 case (1.2%) of pulmonary infiltration of lymphoma. The diagnoses of the remaining 10 cases (11.6%) were not determined. The platelet counts of 33 patients were less than 50×10(9)/L before BAL. None of them developed severe bleeding complications during or after BAL. Transient fever occurred in 10 patients after BAL. Blood cultures showed staphylococcal bacteremia in them and anti-infection therapies were effective. No life-threatening complications occurred in all of the patients during or after BAL. Conclusion: BALF analysis was informative for the diagnosis of pulmonary complication and safe for patients with pulmonary complications after allo-HSCT.
